Loading clinical trials...
Loading clinical trials...
Parenteral Nutrition Support for Patients With Pancreatic Cancer. A Phase II Study.
The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.
To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Universitätsmedizin Berlin - Charité
Berlin, State of Berlin, Germany
Start Date
January 1, 2002
Primary Completion Date
January 1, 2004
Completion Date
May 1, 2004
Last Updated
June 12, 2009
32
ACTUAL participants
parenteral nutrition
DIETARY_SUPPLEMENT
Lead Sponsor
CONKO-Studiengruppe
Collaborators
NCT04550494
NCT05053971
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions